LGR5 and adenocarcinoma: Given the concomitant Lgr5 upregulation in P3 cells, it is plausible that tumour-specific Paneth cells constitute the niche for Lgr5+ CSCs in Apc1638N/+/KRASV12G adenocarcinomas [37].